Anti-LAG3 antibody - ILGEN
Latest Information Update: 12 Feb 2024
At a glance
- Originator ILGEN
- Class Antineoplastics; Immunotherapies; Monoclonal antibodies
- Mechanism of Action CD223 antigen inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Cancer